510(k) K262597
K262597 is an FDA 510(k) premarket notification submitted by Beckman Coulter, Inc. for the device "Access BNP II". The FDA issued a decision of Substantially Equivalent on Oct 20, 2026. The device falls under product code NBC (Test, Natriuretic Peptide), a Class II device regulated under 21 CFR 862.1117. Beckman Coulter, Inc. has 280 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Oct 20, 2026
- Date Received
- Jul 27, 2026
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Test, Natriuretic Peptide
- Device Class
- Class II
- Regulation Number
- 862.1117
- Review Panel
- CH
- Submission Type
- 510(k)
Need the full FDA record for Beckman Coulter, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.